INTRODUCTION

The Potential of Microarray Platforms
With the advent of rapid genome sequencing and large genome databases, it is now possible to take advantage of genetic information in a myriad of ways. One of the most promising technologies is microarrays that use DNA for selective capture of genomic targets (1) . DNA microarrays, also known as biochips, have found widespread use in gene expression analysis, and there are now several academic demonstrations of biochips used in diagnostics (2) . An exciting aspect of biochip platforms is the capability to screen for multiple pathogens simultaneously. DeRisi and co-workers demonstrated a "virus chip" that contained sequences for hundreds of viruses, including many that cause respiratory illness (3) . In the DeRisi work, the genetic material derived from clinical samples was amplified by polymerase chain reaction (PCR) prior to capture, and fluorescent labels were used for detection. Recently, Rowlen and co-workers at the University of Colorado and the Centers for Disease Control in Atlanta developed a microarray (FluChip) for rapid strain analysis of influenza (4) (5) (6) (7) . The FluChip also relied on PCR amplification of targets and fluorescence detection on the array. While DNA microarrays are in some respects ideal for surveillance applications, there are several practical issues that currently prevent their widespread use as diagnostic tools. One such limitation is the use of fluorescence detection, which necessitates the use of expensive, high quality, nonfluorescent substrates, stringent handling conditions, and expensive (>$10K U.S.), non−field portable fluorescence microarray readers. Effective global monitoring of biological pathogens will require simple, robust, and inexpensive detection methods and instrumentation.
Current Colorimetric Methods for Microarrays
There are two commonly used colorimetric methods for signal amplification or detection on microarrays: one based on silver staining or silver nanoparticles (8) and the other based on a colored precipitate that results from alkaline phosphatase (AP) action on a substrate (9) . The alkaline phosphatase reaction typically involves the binding of AP-conjugated streptavidin to biotin-labeled targets on the microarray surface. Addition of a substrate results in a colored, often blue, precipitate formed only where the enzyme is bound to the target. The sensitivity of this system has been demonstrated to be comparable to that of fluorescence detection (10) and the advantages include visual or inexpensive detection and inexpensive reagent costs (∼$2 per assay). The disadvantages of the AP detection method include unstable reagents that must be stored frozen until use and a variable development time that can lead to "overexposure" and higher nonspecific backgrounds (Arrayit AP kit [Telechem Corporation, Sunnyvale, CA, USA] and protocol: www.arrayit.com/ Products/Labeling_Kits/APK/apk.html).
An excellent example of the silver nanoparticle method is the Eppendorf Silverquant kit and associated protocol (Eppendorf [Hamburg, Germany] and protocol: www.eppendorfna.com).The method involves labeling biotinylated DNA targets on the microarray with streptavidin-conjugated colloidal gold, which subsequently serves as a reduction surface for silver ion. The result is a gray silver precipitate that can be visualized by eye or quantified by either transmission (8) or resonance light scattering with sensitivity comparable to fluorescence. The advantages of the silver precipitation method include colorimetric detection and signal stability. Disadvantages include cost per assay (∼$6 U.S.) and unstable reagents that must be refrigerated and used in a temperaturecontrolled environment.
Photopolymerization as a Signal Amplification Method
An innovative approach to detection on microarrays, which eliminates the need for fluorescence reagents and expensive scanners, is based on photopolymerization of an organic monomer. The concept of the non-enzymatic signal amplification (NESA) system is shown schematically in Figure 1 . Detection is based on the use of a photoinitiator as the label rather than a fluor. Once the labeled molecule is captured, the resulting complex is covered in a solution containing monomers and irradiated at a wavelength absorbed by the photoinitiator. Light absorbed by the photoinitiator produces free radicals that propagate by radical addition between the surrounding monomers thereby forming a polymer (much like the photochemical process The first published demonstration of photopolymerization as a signal amplification method used a hydroxyethyl acrylate monomer and a custom-made "macrophotoinitiator" (11) . Although hybridization was not demonstrated, this system enabled visual detection of as few as 1000 biotinylated oligonucleotides on a Biostar Optical ImmunoAssay (BioStar, Louisville, CO, USA) substrate. The disadvantages of the approach included the use of a toxic and volatile monomer, use of a custom-synthesized macrophotoinitiator, use of UV light for initiation (365 nm), and most importantly, the necessity of purging all reagents with argon or nitrogen in order to remove oxygen (which inhibited the reaction). Here we report the performance of a new photopolymerization signal amplification method and demonstrate application to low-density antibody and oligonucleotide microarrays for identification of influenza virus in clinical samples.
MATERIALS AND METHODS
Polymerization Reagents and Method
All reagents and columns were purchased from Sigma Aldrich (St. Louis, MO, USA). As described in this work, the NESA system is a combination of eosin as photoinitiator, polyethyleneglycol diacrylate (PEGDA 575) as the monomer, 1-vinyl-2-pyrrolidinone, and triethanolamine. For some applications, PEGDA was purified by passing it through an inhibitor removal column (Cat. no. 306312). The monomer mix is stable at room temperature and the reaction takes place under ambient conditions (i.e., in air and without temperature control). In general, the NESA protocol involved delivery of 40 μL of the monomer μL of the monomer μ mixture over the array into a Grace Biolabs silicone well (Bend, OR, USA) surrounding the array. Photoactivation was conducted in InDevR's IntelliChip Reader (which has a photoactivation bay fitted with a lightemitting diode [LED] and a transmissionbased reader bay equipped with a digital camera detection system), using light at 532 nm and ∼35 mW/cm 2 35 mW/cm 2 35 mW/cm from an LED array (Norlux, Carol Stream, IL, USA). After photoactivation, excess monomer mixture was removed by a water rinse. In order to stain any resulting polymer, the array was subjected for 2 min to a ∼ 50 ∼ 50 ∼ μM solution μM solution μ of either Congo Red or Eosin Y prepared in 50:50 methanol:H2O. Excess stain was removed by pipet.
A detailed Online Protocol is available at www.BioTechniques.com.
Protein Microarray Preparation
For the protein microarray, monoclonal antibodies to influenza hemagglutinin purchased from BioDesign International (Saco, ME, USA) were spotted at a concentration of 100 μg/mL in a buffer containing 3× SSC, 50 mM Na × SSC, 50 mM Na × 3 PO4, and 0.005% N-lauroylsarcosine sodium salt, pH 7.5. Arrays were spotted onto aldehydefunctionalized glass slides purchased from CEL Associates (Pearland, TX, USA) using a Genetix QArray Mini (Genetix, Hampshire, UK) at 60% relative humidity. A Genetix 300 μm solid tip pin was used with a stamping time of 30 ms and a pitch of 900 μm. The slides were humidified overnight, followed by desiccation for 8 h. Before use the slides were blocked with a powdered milk solution and washed with a phosphate-buffered saline (PBS)/Tween solution. Recombinant hemagglutinin from the strain A/Wyoming/3/2003 (HA) was graciously provided by Protein Science Corporation (Meriden, CT, USA) at 80 μg/ mL in PBS. The detection strategy involved a sandwich assay, where the "label" antibody was conjugated with eosin isothiocyanate (EITC). EITC was covalently attached to monoclonal antibodies by reaction in a bicarbonate buffer (pH 9) for 90 min. Labeled antibodies were purified by passing the reaction mixture through an Amersham Biosciences NAP-5 column (Piscataway, NJ, USA). The concentration of the labeled antibody after purification was ∼2.5 μg/mL.
For HA capture on the protein microarray, recombinant influenza H3 hemagglutinin was incubated with the array for 1 h in a humid environment to prevent evaporation. The array was washed with a PBS/Tween solution followed by a brief water wash. During the labeling step of the sandwich assay, 100 μL of the label μL of the label μ antibody was placed in contact with the array for 20 min at room temperature and washed in solutions of PBS/Tween, PBS, and water.
RNA Extraction from Clinical Samples and RT-PCR Amplification
Coded clinical samples were obtained from Colorado Department of Public Health and Environment (CDPHE). The samples were primarily obtained via nasal wash. RNA was extracted from clinical specimens (known to be positive for the H3N2 subtype of influenza A virus) with the Qiagen QIAampViral RNA Mini kit (Valencia, CA, USA). Extraction of 140 μL of clinical μL of clinical μ material was carried out according to the manufacturer's recommended instructions, and the elution was performed with two 30 μL aliquots. Extracted viral RNA was μL aliquots. Extracted viral RNA was μ amplified by reverse-transcription PCR (RT-PCR) using the Qiagen One-Step RT-PCR Kit (Qiagen). Primers were purchased desalted from Sigma-Genosys (St. Louis, MO, USA). Reverse primers were unmodified, but forward primers were ordered with 5′-phosphorylation to enable enzymatic digestion following PCR. A photoinitiator label (designated P) is used to initiate formation of a solid polymer. The photoinitiator becomes oxidized (P ox nated P) is used to initiate formation of a solid polymer. The photoinitiator becomes oxidized (P ox nated P) is used to initiate formation of a solid polymer. The photoinitiator becomes oxidized (P ) during the photopolymerization process. Polymer forms only where the target and photoinitiator are bound to the microarray. min enzyme deactivation/activation step at 95°C, and 40 cycles of PCR at 96°C for 30 s, 50°C for 30 s, 68°C for 1 min, and a final extension at 72°C for 7 min.
DNA Microarray Preparation
Oligonucleotide sequences for typing influenza in a sandwich assay were taken from the literature (4), specifically capture sequences designated as A-MP-3 and B-MP-1. Capture sequences were also ordered desalted from Sigma-Genosys with a 5′-amino-C6-(T19) modification to enable covalent attachment to aldehyde-modified slides. Label oligonucleotides were purchased from Midland Certified Reagent Company, Inc. (Midland, TX, USA) with a 3′-amino-C7-eosin modification and were HPLC-purified. Capture oligonucleotides were spotted at 10 μM as described μM as described μ above for proteins. After spotting, arrays were kept in a humid environment for 24 h and aged at least 1 day in a light-protected slide storage box before use. Prior to hybridization excess spotting reagents were removed by washing on an orbital shaker in water for 5 min. It was not necessary to block the residual active aldehyde groups by treatment with sodium borohydride since detection by NESA is not affected by background fluorescence.
Digestion of double-stranded DNA by lambda exonuclease was used to enable hybridization of single-stranded DNA to the array (12) . In this method, the forward RT-PCR primer was 5′-phosphorylated and lambda exonuclease was used to digest the phosphorylated strand of the amplified DNA. PCR products (10 μL
. The hybridization mixture was pipeted onto the array and covered with a glass coverslip. The array was placed in a light-protected humidity chamber and allowed to hybridize for 30 min. After 
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Configurable for 96-, 384-, and 1536-well microplate formats Up to 4 fluid inlets for buffers and solutions allow multiple users without bottle changing Research Reports hybridization, the coverslip was removed with a stream of 2× SSC, and hybridized × SSC, and hybridized × arrays were washed on an orbital shaker at room temperature with the following solutions: 2× SSC with 0.1 × SSC with 0.1 × % SDS for 1 min; 2× SSC for 5 min; and 0.2 × SSC for 5 min; and 0.2 × × SSC for × SSC for × 5 min. Arrays were subsequently dried using compressed air and stored in a lightprotected storage box until further use.
Enzyme Comparison Study
For the horseradish peroxidase (HRP) study, the positive control capture sequence was an oligonucleotide (amino-C6 terminated 5′, 25 nt spacer, and 29 nt sequence) designed to be complementary to the label sequence in a one-step hybridization assay (i.e., immobilized capture oligonucleotide is complementary to an eosin-labeled or biotin-labeled target). The negative control was designed with several mismatches to the label sequence. For the HRP system, the label sequence contained a 5′ biotin ′ biotin ′ tag (Sigma Genosys). For NESA the label sequence contained a 5′ eosin tag (BioSource International, Camarillo, CA, USA). Hybridizations on both systems were carried out under the same conditions on slides that had been spotted simultaneously and processed identically.
For NESA, monomer was added after hybridization to the eosin label. The polymer was subsequently formed by irradiation. After washing away excess monomer, the resulting polymer was stained for 5 min, rinsed, and imaged on a Genetix aQuire confocal fluorescence microarray scanner (Genetix). For the HRP system, after hybridization to the biotin label, the array was incubated with 1.25 μg/ mL HRP-conjugated streptavidin (Zymed, South San Francisco, CA, USA) in a 1:1000 in phosphate buffered saline (PBS)/ Tween solution. The substrate was Amplex Red (Molecular Probes, Eugene, OR, USA) diluted to 50 μM in a PBS, 0.04 μM in a PBS, 0.04 μ % hydrogen peroxide solution. A volume of 100 μL was μL was μ added to the array, and the reaction was allowed to proceed for ∼1 h prior to quantification with the fluorescence scanner.
Limit of Detection Study
A sandwich hybridization assay was used to conduct a limit of detection study (i.e., the target oligonucleotide has one region complementary to the capture oligonucleotide and another region complementary to the label oligonucleotide). The label oligonucleotide was tagged with eosin as described above. PCR product from a patient sample positive for influenza A was digested to form ssDNA, which was subsequently prepared at several dilutions. Four influenza microarrays were hybridized for each dilution. The arrays were washed after hybridization and immediately imaged using the fluorescence microarray scanner. Signal intensities from all influenza A positive spots on the microarray were pooled and averaged for all four arrays (20 points per dilution). Average background was obtained from all influenza B negative spots (16 points per dilution). After fluorescence imaging, NESA was conducted and the arrays re-analyzed. A Cy3 calibration slide (Full Moon Biosystems, Sunnyvale, CA, USA), which has specified surface densities of Cy3, was scanned with 532 nm excitation at 50% and 100% photomultiplier tube (PMT) settings. The results were used to determine the Cy3 fluorescence limit of detection and to convert scanned eosin intensities to Cy3/μ eosin intensities to Cy3/μ eosin intensities to Cy3/ m μm μ 2 m 2 m equivalents. 2 equivalents.
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RESULTS
NESA on a Protein Microarray for Influenza
An antibody microarray was used to evaluate NESA's utility for signal amplification from a captured protein in a sandwich assay (Figure 2A ). The arrangement of monoclonal antibodies against the hemagglutinin proteins of influenza A/H3 subtype, A/H1 subtype, and influenza B in a proof-of-principle microarray is shown in Figure 2B . The A/H1 hemagglutinin and B hemagglutinin served as negative controls in an experiment designed to capture A/H3 hemagglutinin. A typical result for capture of H3 hemagglutinin is given in Figure  2C . The resulting polymer was easily visualized by eye with no staining and had an estimated thickness of ∼30 μm, based on μm, based on μ optical microscopy. The image in Figure  2C was acquired on a simple, inexpensive digital camera-based transmission reader (the IntelliChip Reader).
In order to quantify the limit of detection for the polymer system, antibody arrays were stained after polymerization and quantified using a fluorescence microarray scanner. The measured fluorescence signalto-background (S/B) ratio as a function of hemagglutinin concentration is shown in Figure 3 for the range of 1.3 to 13 ng of HA. The measured limit of detection, defined by a S/B ∼3, was 1.3 ng of HA in 100 μL (or μL (or μ 13 ng/mL).
NESA on an Oligonucleotide Microarray
In the first of three model systems, photopolymerization was tested on spotted 
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oligonucleotides with no hybridization. The oligonucleotide microarray layout is shown in Figure 4 in which eosin-labeled amineterminated oligonucleotides were spotted at 21 positions within a 5 × 5 array. Unlabeled oligonucleotides were included at four positions to serve as negative controls. Since the unbound oligonucleotides were washed from the slide, it is reasonable to assume that a monolayer or less of the eosin label is present within each positive spot. NESA was conducted as detailed in the Polymerization Reagents and Method section and the resulting polymer was visible to the eye and easily imaged with a $100 digital camera.
Comparison to Enzyme-based Amplification
In the second model system, a one-step hybridization was used to evaluate the magnitude of signal amplification achieved by photopolymerization relative to a typical post-capture enzymatic system. The NESA amplification factor was determined relative to a HRP/Amplex Red assay. The effective signal amplification factor was calculated as a ratio of the final fluorescence signal to the background on that slide after hybridization. Using this approach, the amplification factor for the HRP system was found to be (2.8 ± 0.2) × 10 × 10 × 5 based on 21 measurements, with error represented by 1 standard deviation ( ). Using the same approach for NESA, the amplification factor was calculated to be (1.06 ± 0.02) ± 0.02) ± × 10 × 10 × 5 .
Limit of Detection by Direct Comparison to Fluorescence
The third oligonucleotide microarray approach used a standard sandwich assay and a clinical sample to determine the limit of detection for NESA. First, the fluorescence limit of detection was determined using a Cy3 calibration curve obtained at a 100% PMT setting ( Figure 5 ). The limit of detection was defined by a signal (S LOD ) equivalent to the background (B) plus 3× the measured (σ) in the background (S LOD = B = B = + 3 + 3 + σ) and was found to be ∼5 Cy3/μm 2 . Since NESA is only used to obtain a qualitative yes/no answer, the photopolymerization limit of detection was defined by the lowest concentration of eosin per square micron that resulted in the formation of visibly detectable polymer. For NESA, the fluorescence signal from eosin measured prior to polymerization was converted to Cy3/μm 2 equivalents using a calibration curve generated from the Full Moon calibration slide scanned at the same PMT setting. Table 1 shows the concentration of Cy3/μm 2 equivalents for each PCR product dilution. Since the fluorescence quantum yield for eosin is reported to be 2-5× higher than that of Cy3, × higher than that of Cy3, × a factor of 3.5 was used to convert Cy3/μ a factor of 3.5 was used to convert Cy3/μ a factor of 3.5 was used to convert Cy3/ m 2 m 2 m equivalents to eosin/μm 2 (Eosin compared to fluorescein, see www.probes.invitrogen.com/handbook/sections/0105.html; fluorescein compared to Cy3, see www. iss.com/resources/yield.html). The highest dilution factor that resulted in an observable polymer spot for NESA was 41×, which is equivalent to ∼17 eosin/ μm 2 . Thus, for this study, NESA was determined to be less sensitive than fluorescence by a factor of 3−4. Additional studies conducted after the acceptance of this manuscript have shown equivalent sensitivity to fluorescence.
NESA on an Oligonucleotide Microarray for Influenza
An oligonucleotide microarray for typing influenza viruses (A and B) was designed to demonstrate the utility of NESA with samples collected from patients. The arrangement of capture oligonucleotides specific for all influenza A viruses are shown in red in Figure 6A . Capture oligonucleotides specific for influenza B viruses, shown in black, served as negative controls. A standard sandwich assay was used with eosin as the photoinitiator. A total of 14 clinical samples were processed as described in the RNA Extraction section in Materials and Methods. Figure 6 , B and C, includes two representative images obtained on the IntelliChip Reader. The polymer is easily detectable by eye without the use of the reader. The quality of the spot morphology (as compared with Figures 2  and 4 ) is due to improvements in the NESA reagent and protocol over a two-year period.
For all 14 clinical samples tested, NESA yielded visibly detectable positive assignments for influenza A positive samples, and no false positives were observed (e.g., no polymer formed on B-specific oligonucleotides).
DISCUSSION
Taken together, the results presented herein demonstrate that NESA is a reliable detection method for both protein and oligonucleotide low-density microarrays. On a low-density influenza antibody microarray, the limit of detection was determined to be 13 ng of HA per mL. While this number is higher than the limit of detection specified for some enzymes (e.g., an HRP-Amplex Red system can achieve ∼0.5 ng/mL detection for some proteins (13)), it is anticipated that further optimization of NESA will provide similar sensitivity. It is interesting to note that the digital camera image A shown in Figure 2C was obtained over two years after the array had been used to capture hemagglutinin. Specifically, the slide had been stored in a black slide transport box at room temperature since December of 2005 with no precautions taken to minimize exposure to ambient ozone. The slide was removed from storage over two years later, stained, and the digital photograph taken. This degree of signal preservation is in stark contrast with the rapid degradation of signal commonly observed for fluorescence-based detection on microarrays (14) .
Proof-of-principle for low-density oligonucleotide microarrays was established using three approaches: (i) a model system with no hybridization, (ii) a one-step hybridization format, and (iii) a standard sandwich hybridization assay format. For the first model system, photopolymerization of eosin-labeled oligonucleotides that were directly spotted onto aldehyde slides was conducted and the resulting polymer easily visualized. In the second system, a one-step hybridization format was used to evaluate the amplification factor achieved by NESA in comparison to a common postcapture enzymatic system. The results indicate that NESA is competitive in terms of overall amplification (∼10 5 ) on a microarray platform. It is worth noting that we have verified that NESA also works with a one-step hybridization where eosin is incorporated into the PCR primer (i.e., no need for label sequences). We have also successfully labeled streptavidin with eosin and demonstrated its use as a photoactive agent (results not shown).
The third system provided a direct comparison with fluorescence detection in a sandwich assay. The detection limit for NESA was determined to be a factor of 3-4 higher than that obtained for Cy3 fluorescence. The same sandwich assay was used to evaluate the reliability of NESA for detection of influenza virus in patient samples on a low-density DNA microarray. The samples were processed using standard methodology (e.g., extraction and RT-PCR amplification) and hybridized to the microarray, and detection was achieved by NESA. and no false negatives were observed. While the viral concentration of influenza in these patient samples was not known, the typical range for patient samples is ∼10 2 -10 9 viruses/mL. Although a small sample set of 14 patient samples is not likely to statistically represent the entire viral concentration range, it is clear that NESA works within that range. In summary, the demonstrated features of NESA include: (i) signal amplification that can be conducted under ambient conditions directly on a low-density microarray within a matter of minutes; (ii) a monomer mixture reagent that costs less than $1 U.S. per assay; (iii) a detection limit that is within an order of magnitude of that for fluorescence; (iv) a signal that is far more stable than fluorescence; (v) nonfluorescence detection that reduces the stringency and expense for microarray substrates (e.g., the aldehyde-coated glass used in these studies cost less than $1.50 per slide); and (vi) visual detection without the need for refrigerated reagents or temperature-controlled reactions, in contrast to enzymatic or silver-based on-chip detection methods. While NESA has not yet eliminated the need for PCR methods for prehybridization amplification of low copy number targets, further optimization is under way. These features indicate that NESA is a robust and inexpensive detection technique that may lead to increased utility of low-density diagnostic microarrays.
